Comfrey Skin Repair, Tested on Rats and Twelve-Week Trials

The Oasis Health Journal · Submitted October 14, 2026 · 10:01 AM EDT

By Marlo Quist · Edited by Priya Raman, C.N.C.

Comfrey has been used for over two thousand years to heal wounds and mend broken bones.

Researchers wanted to know if the active compound actually penetrates human skin.

So they tested it in penetration studies. The allantoin went through the outer layer and into deeper tissue. That proves it gets in. It does not prove it does anything once it arrives. Those are different experiments.

What the Trials Actually Measured

In a 2026 review of clinical trials, topical comfrey root extract preparations significantly outperformed placebo in treating acute back pain, knee osteoarthritis, ankle sprains, and muscle pain. One randomized controlled trial showed comfrey skin repair formulations worked as well as diclofenac gel, a common anti-inflammatory drug, with an excellent safety profile.

The trials were randomized and controlled.

Nobody measured what happened after the trial period ended. The plant's traditional nickname is knitbone. The controlled human evidence for that nickname stops when the funding does.

A 2026 study compared extracts made from comfrey leaves, flowers, and roots. The 70 percent ethanolic flower extract reduced prostaglandin E2, tumor necrosis factor-alpha, and nitrotyrosine levels in rats with induced paw swelling.

Induced paw swelling means somebody swelled the paw on purpose.

The 40 percent ethanolic leaf extract showed antimicrobial activity against Staphylococcus aureus, Enterococcus faecalis, Escherichia coli, and Listeria monocytogenes in broth dilution tests. A rat paw is not a human knee. A petri dish is not an infection. The researchers called the findings promising candidates for multitarget wound-healing development, which means they are not products yet. They are meetings about products.

Allantoin Gets In, But So Do the Alkaloids

Comfrey contains pyrrolizidine alkaloids. Specifically intermedine and lycopsamine. Both are toxic to the liver.

Oral ingestion of comfrey is banned or restricted in Germany, the United Kingdom, Australia, Canada, and by the FDA in the United States because of documented cases of hepatotoxicity.

Topical use is considered safe because systemic absorption of pyrrolizidine alkaloids through intact skin is minimal. A 2026 ethnopharmacological review noted that natural wound healing formulations made from comfrey showed an excellent safety profile in clinical trials when applied to unbroken skin, with no reports of liver damage.

The keyword is unbroken.

An open wound changes the absorption profile. The same review noted that PA-depleted formulations are now prioritized for development to eliminate hepatotoxicity risk entirely.

A PA-depleted formulation is comfrey skin repair with the dangerous part removed.

That raises the question of whether what remains still works the same way. Nobody knows. That study has not been done.

The Evidence Comes From Rats, Ankle Sprains, and a Computer

A 2025 burn study in rats tested oleogel and hydrogel formulations containing plant extracts. The oleogel versions, which are oil-based, performed better than hydrogels in reducing wound size, inflammation, and melanin production over 21 days. The study attributed the results to better pH modulation and adherence to the wound bed.

Burns were induced uniformly using a device called RAPID-3D.

That is an acronym for a machine that burns rats the same way every time so the data is comparable. The study measured wound surface area, skin temperature, pH, and tissue structure under a microscope.

It did not measure pain.

You cannot ask a rat.

Another 2026 study on comfrey herbal skin care identified the key bioactive compounds as allantoin, rosmarinic acid, polysaccharides, and lignans. These compounds inhibit NF-kappa-B and MAPK pathways and suppress pro-inflammatory cytokines, which are the molecules that drive swelling and tissue breakdown during inflammation.

Molecular docking studies suggested that kaempferol-3-O-glucoside interacts with bacterial peptide deformylases, while hyperoside, isoquercitrin, and rosmarinic acid bind to COX-2 and 5-LOX enzymes.

Molecular docking is a computer simulation.

It predicts what might happen. It is not an experiment. It is a guess with equations.

There Is No Standardized Comfrey Product

Different comfrey preparations vary widely in their alkaloid content, allantoin concentration, and extraction solvent. A 70 percent ethanolic extract is not the same as a 40 percent ethanolic extract. A leaf preparation is not the same as a root preparation.

The 2026 review noted pronounced organ-specific pharmacological differences among extracts from leaves, flowers, and roots.

No single quality standard exists.

The absence of standardization means a comfrey root salve on one shelf may contain ten times the allantoin of the one beside it, or five times the pyrrolizidine alkaloids, or be made from a completely different part of the plant. The label will not tell you which. The label will say natural.

Clinical trials used specific proprietary formulations with controlled alkaloid levels.

Those formulations are not the same as the unregulated products sold as comfrey skin repair cream or comfrey ointment in most retail outlets. The trials tested one thing. You are buying a different thing with the same name.

One 2025 review on natural products in hemorrhoid management mentioned comfrey briefly, alongside witch hazel and horse chestnut, as a traditional astringent and wound-healing botanical. It noted therapeutic effects on pain, bleeding, and swelling, then acknowledged challenges related to standardization, quality control, and clinical validation.

Those challenges are still unresolved.

A separate 2025 study on bone tissue engineering mentioned comfrey as one of many plant-origin compounds with supportive effects on bone healing, citing its traditional use in fractures. The study focused on 3D bioprinting scaffolds, not oral or topical comfrey use, and did not measure healing outcomes in living bone.

It measured scaffolds.

The Part You Are Not Supposed to Notice

Comfrey works in controlled trials for sprains, strains, and joint pain when applied topically. It contains a liver toxin. Topical use on intact skin appears safe in the short term.

Long-term safety data does not exist.

Oral use is unsafe. Standardized, PA-depleted formulations are theoretically safer but are not widely available or tested in long trials.

The plant is called knitbone. The clinical evidence stops when the trial stops.

That is the gap.

This article is education and reporting on published research. It is not medical advice, and nothing here is intended to diagnose, treat, cure or prevent any disease. Talk to your own clinician about your own situation.

Sources

1. Anti-Inflammatory and Antimicrobial Activities of Extracts Developed from <i>Symphytum officinale</i> Leaves, Flowers, and Roots: Experimental Evaluation and Molecular Docking Study, International journal of molecular sciences (2026).
2. Integrative Therapies in Wound Healing in Small Animals: An Approach Beyond Traditional Medicine, Veterinary sciences (2026).
3. Ethnopharmacological insights into <i>Symphytum officinale</i> L.: traditional uses, phytochemical composition, therapeutic potential, and clinical-toxicological implications, Frontiers in pharmacology (2026).
4. Optimizing Burn Wound Healing: The Critical Role of pH and Rheological Behavior in Plant-Derived Topical Formulations, Pharmaceutics (2025).
5. Natural Products in Hemorrhoid Management: A Comprehensive Literature Review of Traditional Herbal Remedies and Evidence-Based Therapies, Cureus (2025).
6. Plant-Origin Compounds and Materials for Advancing Bone Tissue Engineering and 3D Bioprinting: Traditional Medicine Aspects and Current Perspectives, Journal of tissue engineering and regenerative medicine (2025).